Select for export Assessing the risk-benefit profile of classical psychedelics: a clinical review of second-wave psychedelic research. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1007/s00213-021-06049-6 PubMed 35022823 Copy citation Copy BibTeX Unknown journal 2022-01-12 Bender D, Hellerstein DJ. Europe PMC Published psilocybin Brain ImagingAgingClinical Trial Clinical Trial More
Select for export Knowledge, Perceptions, and Use of Psychedelics among Individuals with Fibromyalgia. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1080/02791072.2021.2022817 PubMed 35001856 Copy citation Copy BibTeX Journal of Psychoactive Drugs 2022-01-09 Glynos NG, Pierce J, Davis AK, McAfee J, Boehnke KF. Europe PMC Published psilocybin Chronic PainObservational Study Observational Study More
Select for export MDMA/ecstasy use and psilocybin use are associated with lowered odds of psychological distress and suicidal thoughts in a sample of US adults. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/02698811211058923 PubMed 34983249 Copy citation Copy BibTeX Journal of Psychopharmacology 2022-01-04 Jones GM, Nock MK. Europe PMC Published psilocybin Observational StudyAdolescentsSafety Observational Study More
Select for export Lifetime use of MDMA/ecstasy and psilocybin is associated with reduced odds of major depressive episodes. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/02698811211066714 PubMed 34983261 Copy citation Copy BibTeX Journal of Psychopharmacology 2022-01-04 Jones GM, Nock MK. Europe PMC Published psilocybin DepressionAddictionChronic Pain Observational Study More
Select for export Dosing Psychedelics and MDMA. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1007/7854_2021_270 PubMed 34734392 Copy citation Copy BibTeX Unknown journal 2021-12-31 Liechti ME, Holze F. Europe PMC Published psilocybin DepressionAnxietyPTSD Other More
Select for export Psychedelics and Hallucinogens in Psychiatry: Finding New Pharmacological Targets. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.2174/1568026621666211201145800 PubMed 34852736 Copy citation Copy BibTeX Current Topics in Medicinal Chemistry 2021-12-31 Sousa TR, Rema J, Machado S, Novais F. Europe PMC Published psilocybin DepressionAnxietyAddiction Randomized Controlled Trial More
Select for export Psychedelic medicines for mood disorders: current evidence and clinical considerations. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1097/yco.0000000000000759 PubMed 34855694 Copy citation Copy BibTeX PubMed 2021-12-31 Sarris J, Pinzon Rubiano D, Day K, Galvão-Coelho NL, Perkins D. Europe PMC Published psilocybin DepressionPTSDNeuroplasticity Clinical Trial More
Select for export Psychedelics in the Treatment of Headache and Chronic Pain Disorders. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1007/7854_2022_365 PubMed 35546382 Copy citation Copy BibTeX Unknown journal 2021-12-31 Schindler EAD. Europe PMC Published psilocybin Chronic PainHeadache / MigraineReview Article Review Article More
Select for export Neuroimaging Correlates of Treatment Response with Psychedelics in Major Depressive Disorder: A Systematic Review. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/24705470221115342 PubMed 35936944 Copy citation Copy BibTeX Unknown journal 2021-12-31 Kuburi S, Di Passa AM, Tassone VK, Mahmood R, Lalovic A, Ladha KS Europe PMC Published psilocybin DepressionBrain ImagingMechanism of Action Systematic Review More
Select for export LSD Treatment in Persons Suffering From Anxiety Symptoms in Severe Somatic Diseases or in Psychiatric Anxiety Disorders: a Randomized, Double-blind, Placebo-controlled Phase II Study Abstract available at the source but not redistributed here. Read at source. Details Copy citation Copy BibTeX ClinicalTrials.gov 2021-12-21 University Hospital, Basel, Switzerland ClinicalTrials.gov CLINICAL TRIAL psilocybin DepressionAnxietyEnd-of-Life Distress Clinical Trial More
Select for export Announcement of two special issues: behavioural pharmacology of synaptopathies and psychedelic drugs Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1097/fbp.0000000000000662 PubMed 35007231 Copy citation Copy BibTeX Behavioural Pharmacology 2021-12-12 Louk J. M. J. Vanderschuren, Paul Willner, Emily M. Jutkiewicz, Bart Ellenbroek OpenAlex Published psilocybin DepressionAnxietyPTSD Clinical Trial More
Select for export 1H Nuclear Magnetic Resonance: A Future Approach to the Metabolic Profiling of Psychedelics in Human Biofluids? Abstract available at the source but not redistributed here. Read at source. Details DOI 10.3389/fpsyt.2021.742856 PubMed 34966300 Copy citation Copy BibTeX Unknown journal 2021-12-12 Vilca-Melendez S, Uthaug MV, Griffin JL. Europe PMC Published psilocin DepressionMechanism of ActionSystematic Review Systematic Review More
Select for export Molecular insights into psychedelic drug action. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1111/jnc.15540 PubMed 34797943 Copy citation Copy BibTeX Unknown journal 2021-11-30 Slocum ST, DiBerto JF, Roth BL. Europe PMC Published psilocybin DepressionMechanism of ActionReview Article Review Article More
Select for export Bibliometric Analysis of Academic Journal Articles Reporting Results of Psychedelic Clinical Studies Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1101/2021.11.22.21266718 Copy citation Copy BibTeX medRxiv 2021-11-23 Weleff J, Akiki TJ, Barnett BS. medRxiv PREPRINT (not peer reviewed) psilocybin AddictionSafety Other More
Select for export Mestizo Visionary Art of the Americas in the Late Twentieth Century: Hallucinogens, Politics, Aesthetics and Mass Consumer Culture in the United States, Mexico, and Colombia Abstract available at the source but not redistributed here. Read at source. Details DOI 10.7916/d8-efa5-7m74 Copy citation Copy BibTeX Unknown journal 2021-11-22 Cadena Botero OpenAlex Published psilocybin General Other More
Select for export Adults who microdose psychedelics report health related motivations and lower levels of anxiety and depression compared to non-microdosers. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1038/s41598-021-01811-4 PubMed 34795334 Copy citation Copy BibTeX Scientific Reports 2021-11-17 Rootman JM, Kryskow P, Harvey K, Stamets P, Santos-Brault E, Kuypers KPC Europe PMC Published psilocybin DepressionAnxietyMicrodosing Observational Study More
Select for export Human behavioral pharmacology of psychedelics. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/bs.apha.2021.10.003 PubMed 35341564 Copy citation Copy BibTeX Unknown journal 2021-11-10 Strickland JC, Johnson MW. Europe PMC Published psilocybin DepressionAddictionPharmacology Clinical Trial More
Select for export United States National Institutes of Health grant funding for psychedelic-assisted therapy clinical trials from 2006-2020. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.drugpo.2021.103473 PubMed 34624734 Copy citation Copy BibTeX Unknown journal 2021-10-05 Barnett BS, Parker SE, Weleff J. Europe PMC Published psilocybin AddictionClinical TrialReview Article Clinical Trial More
Select for export Low doses of LSD reduce broadband oscillatory power and modulate event-related potentials in healthy adults. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1007/s00213-021-05991-9 PubMed 34613430 Copy citation Copy BibTeX Unknown journal 2021-10-05 Murray CH, Tare I, Perry CM, Malina M, Lee R, de Wit H. Europe PMC Published psilocybin AnxietyBrain ImagingDefault Mode Network Other More
Select for export Psilocin, LSD, mescaline, and DOB all induce broadband desynchronization of EEG and disconnection in rats with robust translational validity. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1038/s41398-021-01603-4 PubMed 34601495 Copy citation Copy BibTeX Translational Psychiatry 2021-10-01 Vejmola Č, Tylš F, Piorecká V, Koudelka V, Kadeřábek L, Novák T Europe PMC Published psilocybinpsilocin Brain Imaging Other More
